Simon Says podcast

SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

1/19/2023
0:00
NaN:NaN:NaN
Rewind 15 seconds
Fast Forward 15 seconds
David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s […]

More episodes from "Simon Says"